Inhibition of dnajc12 inhibited tumorigenesis of rectal cancer via downregulating hspa4 expression

HIGHLIGHTS

  • who: Expression et al. from the Third Ward of Cancer Center, The PLA Navy Anqing Hospital, Anqing, Anhui, China have published the research: Inhibition of DNAJC12 Inhibited Tumorigenesis of Rectal Cancer via Downregulating HSPA4 Expression, in the Journal: Evidence-Based Complementary and Alternative Medicine 120 of 21/09/2022
  • what: This study aimed to determine the biology function and mechanism of DNAJC12 in rectal cancer (RC). The authors provided the first evidence of the binding between DNAJC12 and HSPA4 in RC. This study provided a new insight into the regulatory mechanisms of DNAJC12 on RC . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?